文献速递腹部泌尿生殖技术与安全CT

肾细胞癌的综合纹理特征分析框架:基于CT图像的病理、预后与基因组评估

A comprehensive texture feature analysis framework of renal cell carcinoma: pathological, prognostic, and genomic evaluation based on CT images.
PubMed 文献 · Eur Radiol · 2021-11-20

本研究回顾性分析五个开源队列中443例肾细胞癌患者的569幅增强CT图像,随机划分训练集与测试集,利用CT纹理特征构建机器学习模型分割病灶并预测组织学亚型、肿瘤分期和病理分级。模型分类性能与放射科医师相当,组织学亚型、肿瘤分期和病理分级的AUC分别为0.83、0.80和0.77(95%CI);特定纹理特征与临床预后相关,并与基因组特征呈强统计相关(R2=0.83),结构方程模型证实CT特征与病理(β=-0.75)及分子亚型(β=-0.30)显著相关。

要点

  • CT纹理特征模型可分割肾脏(平均Dice系数0.96)和癌区(0.88)。
  • 组织学亚型、肿瘤分期和病理分级的分类AUC分别为0.83、0.80和0.77(95%CI)。
  • 特定定量CT特征与临床预后相关,且与基因组特征强相关(R2=0.83)。

核心结论

  • 该框架在肾细胞癌病理分类中表现出高性能,与放射科医师相当,定量图像分析可推断预后和基因组特征。

研究设计与样本

  • 回顾性分析五个开源队列中443例肾细胞癌患者的569幅增强CT图像,随机划分训练集与测试集以训练机器学习算法,评估分割、组织学亚型、肿瘤分期和病理分级预测,并计算Dice系数、准确度和AUC等指标。

关键影像表现/征象

  • 分割任务中肾脏平均Dice系数为0.96,癌区为0.88。
  • 定量分解预测模型显示特定纹理特征对组织学亚型和肿瘤分期分类有贡献。
  • 结构方程模型显示CT特征与病理(β=-0.75)及分子亚型(β=-0.30)显著相关。

诊断标准与关键数值

  • 组织学亚型分类AUC为0.83(95%CI,[公式见原文]0.1)。
  • 肿瘤分期分类AUC为0.80(95%CI,[公式见原文]0.1)。
  • 病理分级分类AUC为0.77(95%CI,[公式见原文]0.1)。

临床应用与阅片要点

  • 该分析框架可用于肾细胞癌病理分类,性能与放射科医师相当。
  • 定量CT纹理分析可推断肾细胞癌的总体生存和分子特征。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We tried to realize accurate pathological classification, assessment of prognosis, and genomic molecular typing of renal cell carcinoma by CT texture feature analysis. To determine whether CT texture features can perform accurate pathological classification and evaluation of prognosis and genomic characteristics in renal cell carcinoma.

METHODS: Patients with renal cell carcinoma from five open-source cohorts were analyzed retrospectively in this study. These data were randomly split to train and test machine learning algorithms to segment the lesion, predict the histological subtype, tumor stage, and pathological grade. Dice coefficient and performance metrics such as accuracy and AUC were calculated to evaluate the segmentation and classification model. Quantitative decomposition of the predictive model was conducted to explore the contribution of each feature. Besides, survival analysis and the statistical correlation between CT texture features, pathological, and genomic signatures were investigated.

RESULTS: A total of 569 enhanced CT images of 443 patients (mean age 59.4, 278 males) were included in the analysis. In the segmentation task, the mean dice coefficient was 0.96 for the kidney and 0.88 for the cancer region. For classification of histologic subtype, tumor stage, and pathological grade, the model was on a par with radiologists and the AUC was 0.83 [Formula: see text] 0.1, 0.80 [Formula: see text] 0.1, and 0.77 [Formula: see text] 0.1 at 95% confidence intervals, respectively. Moreover, specific quantitative CT features related to clinical prognosis were identified. A strong statistical correlation (R2 = 0.83) between the feature crosses and genomic characteristics was shown. The structural equation modeling confirmed significant associations between CT features, pathological (β = - 0.75), and molecular subtype (β = - 0.30).

CONCLUSIONS: The framework illustrates high performance in the pathological classification of renal cell carcinoma. Prognosis and genomic characteristics can be inferred by quantitative image analysis.

KEY POINTS: • The analytical framework exhibits high-performance pathological classification of renal cell carcinoma and is on a par with human radiologists. • Quantitative decomposition of the predictive model shows that specific texture features contribute to histologic subtype and tumor stage classification. • Structural equation modeling shows the associations of genomic characteristics to CT texture features. Overall survival and molecular characteristics can be inferred by quantitative CT texture analysis in renal cell carcinoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu, Wu, Yang, et al. A comprehensive texture feature analysis framework of renal cell carcinoma: pathological, prognostic, and genomic evaluation based on CT images. Eur Radiol. 2021. PMID: 34800150. doi:10.1007/s00330-021-08353-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。